Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT05671276

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05671276
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05671276. Randomized; single masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2024-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion
Condition
Left Atrial Appendage Occlusion
Condition
Silent Cerebral Embolism
Intervention (Drug)
aspirin and clopidogrel
Intervention (Drug)
Rivaroxaban
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University (class: other)
Collaborator
Second Affiliated Hospital of Nantong University (class: other)
Collaborator
Jiangsu Taizhou People's Hospital (class: other)

Record details

Record id
cardio:ct-nct05671276
Content hash
5d06aa7a5fb84b462ab2db6a78074f8c960e62e64f5e7fad7d3eec9bbcd04c3a